Object. The extent of tumor resection that should be undertaken in patients with glioblastoma multiforme (GBM) remains controversial. The purpose of this study was to identify significant independent predictors of survival in these patients and to determine whether the extent of resection was associated with increased survival time.
Methods. The authors retrospectively analyzed 416 consecutive patients with histologically proven GBM who underwent tumor resection at the authors' institution between June 1993 and June 1999. Volumetric data and other tumor characteristics identified on magnetic resonance (MR) imaging were collected prospectively.
Conclusions. Five independent predictors of survival were identified: age, Karnofsky Performance Scale (KPS) score, extent of resection, and the degree of necrosis and enhancement on preoperative MR imaging studies. A significant survival advantage was associated with resection of 98% or more of the tumor volume (median survival 13 months, 95% confidence interval [CI] 11.4–14.6 months), compared with 8.8 months (95% CI 7.4–10.2 months; p < 0.0001) for resections of less than 98%. Using an outcome scale ranging from 0 to 5 based on age, KPS score, and tumor necrosis on MR imaging, we observed significantly longer survival in patients with lower scores (1–3) who underwent aggressive resections, and a trend toward slightly longer survival was found in patients with higher scores (4–5). Gross-total tumor resection is associated with longer survival in patients with GBM, especially when other predictive variables are favorable.
AlbertFKForstingMSartorKet al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.Neurosurgery34:45–611994Neurosurgery 34:
AmmiratiMVickNLiaoYet al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.Neurosurgery21:201–2061987Neurosurgery 21:
CurranWJJrScottCBHortonJet al:Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.J Neurooncol12:219–2271992J Neurooncol 12:
HessKR: Extent of resection as a prognostic variable in the treatment of gliomas.J Neurooncol42:227–2311999Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:
SegallHDDestianSNelsonMDJret al: CT and MR imaging in malignant gliomasApuzzoMLJ (ed): Malignant Cerebral Glioma.Park Ridge, IL: American Association of Neurological Surgeons199063–77Malignant Cerebral Glioma.
ShapiroWRGreenSBBurgerPCet al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001.J Neurosurg71:1–91989J Neurosurg 71: